Optimization and SAR for dual ErbB-1/ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series

KG Petrov, YM Zhang, M Carter, GS Cockerill…

Index: Bioorganic and Medicinal Chemistry Letters, , vol. 16, # 17 p. 4686 - 4691

Full Text: HTML

Citation Number: 122

Abstract

... Bioorganic & Medicinal Chemistry Letters. Volume 16, Issue 17, 1 September 2006, Pages 4686–4691. Cover image Cover image. Optimization and SAR for dual ErbB-1/ErbB- 2 tyrosine kinase inhibition in the 6-furanylquinazoline series. ...

Related Articles:

Synthetic approaches to the 2011 new drugs

[EP1481971 A1, ; Page 8-9 ;]

Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth …

[Journal of Medicinal Chemistry, , vol. 53, # 24 p. 8546 - 8555]

Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth …

[Journal of Medicinal Chemistry, , vol. 53, # 24 p. 8546 - 8555]

Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth …

[Journal of Medicinal Chemistry, , vol. 53, # 24 p. 8546 - 8555]

Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth …

[Journal of Medicinal Chemistry, , vol. 53, # 24 p. 8546 - 8555]

More Articles...